INVO Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018 - 2015
Market Capitalization	3	3	5	39	15	-	Upgrade
Market Cap Growth	-64.03%	-35.20%	-86.81%	162.06%	-	-	Upgrade
Enterprise Value	8	11	7	35	6	-1	Upgrade
PE Ratio	-	-0.42	-0.47	-5.87	-1.79	-	Upgrade
PS Ratio	0.69	1.11	6.27	9.39	14.38	-	Upgrade
PB Ratio	287.30	3.74	-5.27	5.35	2.60	-	Upgrade
P/FCF Ratio	-0.64	-0.64	-0.78	-6.03	-3.07	-	Upgrade
P/OCF Ratio	-0.72	-0.70	-0.78	-6.48	-3.12	-	Upgrade
EV/Sales Ratio	1.99	3.77	9.12	8.48	5.37	-0.53	Upgrade
EV/EBITDA Ratio	-1.44	-1.66	-0.70	-6.76	-1.02	0.45	Upgrade
EV/EBIT Ratio	-1.36	-1.61	-0.69	-6.55	-1.01	0.44	Upgrade
EV/FCF Ratio	-1.93	-2.19	-1.13	-5.44	-1.14	-0.60	Upgrade
Debt / Equity Ratio	593.53	9.28	-2.49	0.26	0.13	-0.12	Upgrade
Debt / EBITDA Ratio	-1.04	-1.20	-0.23	-0.36	-0.14	-0.26	Upgrade
Debt / FCF Ratio	-1.39	-1.59	-0.37	-0.29	-0.15	0.35	Upgrade
Quick Ratio	0.07	0.05	0.05	4.58	4.42	0.83	Upgrade
Current Ratio	0.19	0.15	0.18	5.03	4.61	1.03	Upgrade
Asset Turnover	0.26	0.23	0.14	0.43	0.26	0.53	Upgrade
Interest Coverage	-6.92	-7.65	-182.19	-4.26	-1.94	-4.59	Upgrade
Return on Equity (ROE)	6590.60%	9145.70%	-470.70%	-134.00%	539.20%	63.10%	Upgrade
Return on Assets (ROA)	-43.40%	-60.50%	-183.60%	-68.70%	-210.00%	-77.00%	Upgrade
Return on Capital (ROIC)	-89.56%	-73.73%	-730.35%	-56.63%	-84.91%	54.91%	Upgrade
Earnings Yield	-242.68%	-240.49%	-211.26%	-17.03%	-55.98%	-	Upgrade
FCF Yield	-148.62%	-155.64%	-128.32%	-16.59%	-32.62%	-	Upgrade
Buyback Yield / Dilution	-510.74%	-158.35%	-14.02%	-93.68%	-13.08%	-5.45%	Upgrade
Total Shareholder Return	-510.74%	-158.35%	-14.02%	-93.68%	-13.08%	-5.45%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).